Tumor-Tropic Adipose-Derived Mesenchymal Stromal Cell Mediated Bi2Se3 Nano-Radiosensitizers Delivery for Targeted Radiotherapy of Non-Small Cell Lung Cancer
Jingfang Xiao,Lijuan Zeng,Shuaishuai Ding,Yemiao Chen,Xiao Zhang,Xiu-wu Bian,Gan Tian
First published: 23 February 2022 
https://doi.org/10.1002/adhm.202200143
PubMed=4357758; DOI=10.1093/jnci/51.5.1417
Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., Parks W.P.In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.J. Natl. Cancer Inst. 51:1417-1423(1973)
PubMed=175022; DOI=10.1002/ijc.2910170110
Lieber M.M., Smith B.T., Szakal A., Nelson-Rees W.A., Todaro G.J.A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells.
Int. J. Cancer 17:62-70(1976)
PubMed=327080; DOI=10.1093/jnci/59.1.221
Fogh J., Fogh J.M., Orfeo T.One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.J. Natl. Cancer Inst. 59:221-226(1977)
PubMed=833871; DOI=10.1093/jnci/58.2.209
Fogh J., Wright W.C., Loveless J.D.Absence of HeLa cell contamination in 169 cell lines derived from human tumors.J. Natl. Cancer Inst. 58:209-214(1977)
PubMed=842942; DOI=10.1164/arrd.1977.115.2.285
Smith B.T.Cell line A549: a model system for the study of alveolar type II cell function.Am. Rev. Respir. Dis. 115:285-293(1977)
PubMed=924690; DOI=10.1002/ijc.2910200505
Kerbel R.S., Pross H.F., Leibovitz A.Analysis of established human carcinoma cell lines for lymphoreticular-associated membrane receptors.Int. J. Cancer 20:673-679(1977)
PubMed=22282976; DOI=10.1093/carcin/1.1.21
Day R.S. III, Ziolkowski C.H.J., Scudiero D.A., Meyer S.A., Mattern M.R.Human tumor cell strains defective in the repair of alkylation damage.Carcinogenesis 1:21-32(1980)
PubMed=6935474; DOI=10.1093/jnci/66.2.239
Wright W.C., Daniels W.P., Fogh J.Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.J. Natl. Cancer Inst. 66:239-247(1981)
PubMed=7459858
Rousset M., Zweibaum A., Fogh J.Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.Cancer Res. 41:1165-1170(1981)
PubMed=7065527; DOI=10.1164/arrd.1982.125.2.222
Hay R.J., Williams C.D., Macy M.L., Lavappa K.S.Cultured cell lines for research on pulmonary physiology available through the American Type Culture Collection.Am. Rev. Respir. Dis. 125:222-232(1982)
PubMed=6148444; DOI=10.1093/jnci/73.4.801
Morstyn G., Russo A., Carney D.N., Karawya E., Wilson S.H., Mitchell J.B.Heterogeneity in the radiation survival curves and biochemical properties of human lung cancer cell lines.J. Natl. Cancer Inst. 73:801-807(1984)
PubMed=6500159; DOI=10.1159/000163283
Gershwin M.E., Lentz D., Owens R.B.Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice.Exp. Cell Biol. 52:361-370(1984)
PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.Human tumor lines for cancer research.Cancer Invest. 4:157-184(1986)
PubMed=3940644
Brower M., Carney D.N., Oie H.K., Gazdar A.F., Minna J.D.Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.Cancer Res. 46:798-806(1986)
PubMed=3945555; DOI=10.1093/nar/14.2.843
Valenzuela D.M., Groffen J.Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene.Nucleic Acids Res. 14:843-852(1986)
PubMed=3129183
Hubbard W.C., Alley M.C., McLemore T.L., Boyd M.R.Evidence for thromboxane biosynthesis in established cell lines derived from human lung adenocarcinomas.Cancer Res. 48:2674-2677(1988)
PubMed=3335022
Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.Feasibility of drug screening with panels ofhuman tumor cell lines using a microculture tetrazolium assay.Cancer Res. 48:589-601(1988)
PubMed=3413074; DOI=10.1073/pnas.85.16.6042
Pereira-Smith O.M., Smith J.R.Genetic analysis of indefinite division in human cells: identification of four complementation groups.Proc. Natl. Acad. Sci. U.S.A. 85:6042-6046(1988)
PubMed=2388294; DOI=10.1093/jnci/82.17.1420
McLemore T.L., Litterst C.L., Coudert B.P., Liu M.C., Hubbard W.C., Adelberg S., Czerwinski M.J., McMahon N.A., Eggleston J.C., Boyd M.R.Metabolic activation of 4-ipomeanol in human lung, primary pulmonary carcinomas, and established human pulmonary carcinoma cell lines.J. Natl. Cancer Inst. 82:1420-1426(1990)
PubMed=2041050; DOI=10.1093/jnci/83.11.757
Monks A., Scudiero D.A., Skehan P., Shoemaker R.H., Paull K., Vistica D.T., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Campbell H., Mayo J.G., Boyd M.R.Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.J. Natl. Cancer Inst. 83:757-766(1991)
PubMed=8286010
Kiura K., Watarai S., Shibayama T., Ohnoshi T., Kimura I., Yasuda T.Inhibitory effects of cholera toxin on in vitro growth of human lung cancer cell lines.Anticancer Drug Des. 8:417-428(1993)
PubMed=7736387; DOI=10.1002/1097-0142(19950515)75:10
Campling B.G., Sarda I.R., Baer K.A., Pang S.C., Baker H.M., Lofters W.S., Flynn T.G.Secretion of atrial natriuretic peptide and vasopressin by small cell lung cancer.Cancer 75:2442-2451(1995)
PubMed=8626706; DOI=10.1074/jbc.271.19.11477
Quinn K.A., Treston A.M., Unsworth E.J., Miller M.-J., Vos M., Grimley C., Battey J., Mulshine J.L., Cuttitta F.Insulin-like growth factor expression in human cancer cell lines.J. Biol. Chem. 271:11477-11483(1996)
PubMed=9023415; DOI=10.1006/cimm.1996.1062
Seki N., Hoshino T., Kikuchi M., Hayashi A., Itoh K.HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.Cell. Immunol. 175:101-110(1997)
PubMed=9178645; DOI=10.1006/cimm.1997.1108
Nakao M., Sata M., Saitsu H., Yutani S., Kawamoto M., Kojiro M., Itoh K.CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma.Cell. Immunol. 177:176-181(1997)
PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.Screening the p53 status of human cell lines using a yeast functional assay.Mol. Carcinog. 19:243-253(1997)
PubMed=9636188; DOI=10.1073/pnas.95.13.7556
Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., Schreiber R.D.Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.Proc. Natl. Acad. Sci. U.S.A. 95:7556-7561(1998)
PubMed=9649128; DOI=10.1038/bjc.1998.361
Yi S., Chen J.-R., Viallet J., Schwall R.H., Nakamura T., Tsao M.-S.Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines.
Br. J. Cancer 77:2162-2170(1998)
PubMed=10358721; DOI=10.18926/AMO/31626
Matsushita A., Tabata M., Ueoka H., Kiura K., Shibayama T., Aoe K., Kohara H., Harada M.Establishment of a drug sensitivity panel using human lung cancer cell lines.
Acta Med. Okayama 53:67-75(1999)
PubMed=10700174; DOI=10.1038/73432
Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P.T., Iyer V., Jeffrey S.S., van de Rijn M., Waltham M., Pergamenschikov A., Lee J.C.F., Lashkari D., Shalon D., Myers T.G., Weinstein J.N., Botstein D., Brown P.O.Systematic variation in gene expression patterns in human cancer cell lines.Nat. Genet. 24:227-235(2000)
PubMed=11005564; DOI=10.1038/sj.neo.7900094
Kohno T., Sato T., Takakura S., Takei K., Inoue K., Nishioka M., Yokota J.Mutation and expression of the DCC gene in human lung cancer.Neoplasia 2:300-305(2000)
PubMed=11369051; DOI=10.1016/S0165-4608(00)00363-0
Luk C., Tsao M.-S., Bayani J., Shepherd F., Squire J.A.Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.Cancer Genet. Cytogenet. 125:87-99(2001)
PubMed=11958134
Zhan X.-Q., Guan Y.-J., Li C., Chen Z.-C., Xie J.-Y., Chen P., Liang S.-P.Differential proteomic analysis of human lung adenocarcinoma cell line A-549 and of normal cell line HBE.Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 34:50-56(2002)
PubMed=12661003; DOI=10.1002/gcc.10196
Seitz S., Wassmuth P., Plaschke J., Schackert H.K., Karsten U., Santibanez-Koref M.-F., Schlag P.M., Scherneck S.Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines.Genes Chromosomes Cancer 37:29-35(2003)
PubMed=12794755; DOI=10.1002/ijc.11184
Endoh H., Yatabe Y., Shimizu S., Tajima K., Kuwano H., Takahashi T., Mitsudomi T.RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.Int. J. Cancer 106:45-51(2003)
PubMed=14581340
Yokoi S., Yasui K., Iizasa T., Imoto I., Fujisawa T., Inazawa J.TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.Clin. Cancer Res. 9:4705-4713(2003)
PubMed=15746151; DOI=10.1093/hmg/ddi092
Izumi H., Inoue J., Yokoi S., Hosoda H., Shibata T., Sunamori M., Hirohashi S., Inazawa J., Imoto I.Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers.Hum. Mol. Genet. 14:997-1007(2005)
PubMed=15748285; DOI=10.1186/1479-5876-3-11
Adams S., Robbins F.-M., Chen D., Wagage D., Holbeck S.L., Morse H.C. III, Stroncek D., Marincola F.M.HLA class I and II genotype of the NCI-60 cell lines.J. Transl. Med. 3:11-11(2005)
PubMed=15900046; DOI=10.1093/jnci/dji133
Mashima T., Oh-hara T., Sato S., Mochizuki M., Sugimoto Y., Yamazaki K., Hamada J., Tada M., Moriuchi T., Ishikawa Y., Kato Y., Tomoda H., Yamori T., Tsuruo T.p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.J. Natl. Cancer Inst. 97:765-777(2005)
PubMed=15999539
Matsumura T., Takigawa N., Kiura K., Shibayama T., Chikamori M., Tabata M., Ueoka H., Tanimoto M.Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: evidence of cisplatin accumulation and topoisomerase I activity.
In Vivo 19:717-721(2005)
PubMed=17088437; DOI=10.1158/1535-7163.MCT-06-0433
Ikediobi O.N., Davies H., Bignell G.R., Edkins S., Stevens C., O'Meara S., Santarius T., Avis T., Barthorpe S., Brackenbury L., Buck G., Butler A., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Hunter C., Jenkinson A., Jones D., Kosmidou V., Lugg R., Menzies A., Mironenko T., Parker A., Perry J., Raine K., Richardson D., Shepherd R., Small A., Smith R., Solomon H., Stephens P., Teague J.W., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Reinhold W.C., Weinstein J.N., Stratton M.R., Futreal P.A., Wooster R.Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.Mol. Cancer Ther. 5:2606-2612(2006)
PubMed=17331233; DOI=10.1186/1471-2164-8-62
Nymark P., Lindholm P.M., Korpela M.V., Lahti L., Ruosaari S., Kaski S., Hollmen J., Anttila S., Kinnula V.L., Knuutila S.Gene expression profiles in asbestos-exposed epitheli l and mesothelial lung cell lines.BMC Genomics 8:62-62(2007)
PubMed=17332333; DOI=10.1158/0008-5472.CAN-06-3339
Okabe T., Okamoto I., Tamura K., Terashima M., Yoshida T., Satoh T., Takada M., Fukuoka M., Nakagawa K.Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification.Cancer Res. 67:2046-2053(2007)
PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x
Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y., Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K., Yasumoto K.Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/immunological responses both in vivo and in vitro.Cancer Sci. 98:1048-1054(2007)
PubMed=18083107; DOI=10.1016/j.cell.2007.11.025
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.Cell 131:1190-1203(2007)
PubMed=19372543; DOI=10.1158/1535-7163.MCT-08-0921
Lorenzi P.L., Reinhold W.C., Varma S., Hutchinson A.A., Pommier Y., Chanock S.J., Weinstein J.N.DNA fingerprinting of the NCI-60 cell line panel.Mol. Cancer Ther. 8:713-724(2009)
PubMed=19472407; DOI=10.1002/humu.21028
Blanco R., Iwakawa R., Tang M., Kohno T., Angulo B., Pio R., Montuenga L.M., Minna J.D., Yokota J., Sanchez-Cespedes M.A gene-alteration profile of human lung cancer cell lines.Hum. Mutat. 30:1199-1206(2009)
PubMed=19608861; DOI=10.1126/science.1175371
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M.Lysine acetylation targets protein complexes and co-regulates major cellular functions.Science 325:834-840(2009)
PubMed=19657000
Rubporn A., Srisomsap C., Subhasitanont P., Chokchaichamnankit D., Chiablaem K., Svasti J., Sangvanich P.Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line.Cancer Genomics Proteomics 6:229-237(2009)
PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F., Campbell P.J., Futreal P.A., Stratton M.R.Signatures of mutation and selection in the cancer genome.Nature 463:893-898(2010)
PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.Cancer Res. 70:2158-2164(2010)
PubMed=20545000; DOI=10.3724/SP.J.1141.2010.02113
Peng K.-J., Wang J.-H., Su W.-T., Wang X.-C., Yang F.-T., Nie W.-H.Characterization of two human lung adenocarcinoma cell lines by reciprocal chromosome painting.Dong Wu Xue Yan Jiu 31:113-121(2010)
PubMed=21060948; DOI=10.1039/c0mb00055h
Yu G., Xiao C.-L., Lu C.-H., Jia H.-T., Ge F., Wang W., Yin X.-F., Jia H.-L., He J.-X., He Q.-Y.Phosphoproteome profile of human lung cancer cell line A549.Mol. Biosyst. 7:472-479(2011)
PubMed=22068913<span style="font-family
Tumor-Tropic Adipose-Derived Mesenchymal Stromal Cell Mediated Bi2Se3 Nano-Radiosensitizers Delivery for Targeted Radiotherapy of Non-Small Cell Lung Cancer
Jingfang Xiao,Lijuan Zeng,Shuaishuai Ding,Yemiao Chen,Xiao Zhang,Xiu-wu Bian,Gan Tian
First published: 23 February 2022
4001790116
